Citizens & Northern Corporation
NASDAQ:CZNCBanks - Regional
+$0.08 today
- Market cap
- $490.77M
- Beta
- 0.42
- P/E (TTM)
- 22.0
- EPS (TTM)
- $0.99
- Dividend yield
- 5.17%
Volume 0.08M
Average 0.04M
CZNC Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Citizens & Northern CorporationNASDAQ: CZNC
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How CZNC compares with its peers on the latest reported figures
- CZNC's LTM Mar 2026 research & development of $0 is the highest of the 11 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for CZNC, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding CZNC) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for CZNC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 108.95M | 115.48M | 136.24M | 155.47M | 154.19M |
| Cost of Revenue | 10.22M | 16.77M | 33.29M | 51.16M | 53.44M |
| Gross Profit | 98.73M | 98.7M | 102.95M | 104.31M | 100.75M |
| Gross Margin | 90.6% | 85.5% | 75.6% | 67.1% | 65.3% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 37.6M | 41.83M | 44.2M | 44.93M | 53.25M |
| Operating Expenses | 61.04M | 66.35M | 72.47M | 72.44M | 72.11M |
| Depreciation & Amortization | 2.13M | 2.39M | 2.15M | 2.18M | 2.36M |
| EBITDA | 39.82M | 34.74M | 32.63M | 34.05M | 31.01M |
| EBITDA Margin | 36.5% | 30.1% | 24.0% | 21.9% | 20.1% |
| Operating Income | 37.69M | 32.35M | 30.48M | 31.87M | 28.64M |
| Operating Margin | 34.6% | 28.0% | 22.4% | 20.5% | 18.6% |
| Interest Income | 84.5M | 92.65M | 113.5M | 128.08M | 139.22M |
| Interest Expense | 6.56M | 9.52M | 33.1M | 48.96M | 47.36M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 37.69M | 32.35M | 30.48M | 31.87M | 28.64M |
| Pre-Tax Margin | 34.6% | 28.0% | 22.4% | 20.5% | 18.6% |
| Income Tax Expense | 7.13M | 5.73M | 6.34M | 5.91M | 5.22M |
| Net Income | 30.55M | 26.62M | 24.15M | 25.96M | 23.43M |
| Net Margin | 28.0% | 23.1% | 17.7% | 16.7% | 15.2% |
| EPS (Basic) | 1.92 | 1.71 | 1.57 | 1.69 | 1.46 |
| EPS (Diluted) | 1.92 | 1.71 | 1.57 | 1.69 | 1.46 |
| Weighted Avg Shares | 15.77M | 15.46M | 15.24M | 15.26M | 15.95M |
| Weighted Avg Shares (Diluted) | 15.77M | 15.46M | 15.24M | 15.26M | 15.95M |
Citizens & Northern Corporation
NASDAQ:CZNC
Intrinsic Alpha fair value
Locked
Current Price
$27.34
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.